BSC Medical - Gateway to your medical needsNew and Used Medical Equipment

Latest News

Celgene Provides Update on GED-0301 (mongersen) Inflammatory Bowel Disease Program
Fri, 20 Oct 2017 12:58:22 GMT

SUMMIT, N.J.--(Healthcare Sales & Marketing Network)-- Celgene Corporation (NASDAQ: CELG) today announced that the GED-0301 (mongersen) phase III REVOLVE trial (CD-002) in Crohn's disease (CD) and the extension trial (SUSTAIN, CD-004) will discontinue. Cel...
Biopharmaceuticals, Gastroenterology
Celgene, mongersen, REVOLVE trial, Crohn's disease

Medeon Biodesign Announces Successful Clinical Use of AbClose(TM) Laparoscopic Port Site Closure Device in the United States
Fri, 20 Oct 2017 12:45:24 GMT

TAIPEI, Taiwan, Oct. 20, 2017 -- (Healthcare Sales & Marketing Network) -- Medeon Biodesign, Inc., a publicly traded medical device company headquartered in Taipei, is pleased to announce that its innovative laparoscopic port site closure device, AbClose�...
Devices, Surgery
Medeon Biodesign, AbClose, laparoscopy, port site wound closure

Bayer Appoints Jennifer Brendel to Vice President, Head of U.S. Consumer Health Communications
Thu, 19 Oct 2017 15:17:42 GMT

WHIPPANY, N.J., Oct. 19, 2017 -- (Healthcare Sales & Marketing Network) -- Bayer is proud to announce today the appointment of Jennifer Brendel to Vice President of Communications for the company's Consumer Health Division in the United States. Brendel...
Biopharmaceuticals, Personnel

Spinal Singularity Closes Seed Funding Round for $3.1M
Thu, 19 Oct 2017 15:14:21 GMT

SAN CLEMENTE, Calif., Oct. 19, 2017 -- (Healthcare Sales & Marketing Network) -- Derek Herrera, the founder of Spinal Singularity, announced the closing of an equity investment in the amount of $3.1M. The round was led by Baker & Eastlack Ventures and in...
Devices, Urology, Venture Capital
Spinal Singularity, Connected Catheter, Lower Urinary Tract Dysfunction

Imprimis Pharmaceuticals to Offer Compounded Cyclosporine Alternative to Restasis(R)
Thu, 19 Oct 2017 15:10:54 GMT

Initial prescriptions will be 99 cents for a one month supply with refills starting at $79 per month, including shipping SAN DIEGO, Oct. 19, 2017 -- (Healthcare Sales & Marketing Network) -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), an ophthalmol...
Biopharmaceuticals, Ophthalmology, Product Launch
Imprimis Pharmaceuticals, Cyclosporine, Restasis, Dry Eye

Kent Imaging Revolutionizes Perfusion Imaging with their FDA-Cleared KD203
Thu, 19 Oct 2017 13:11:42 GMT

CALGARY, Oct. 19, 2017 -- (Healthcare Sales & Marketing Network) - Kent Imaging, a leading provider of near infrared imaging solutions, announced today that the U.S. Food and Drug Administration (FDA) has cleared their multispectral Medical Imaging Device...
Devices, Wound Care, FDA
Kent Imaging, Kent camera, multispectral medical imaging

European Court of Appeal Rejects Varian's Attempt to Reverse Customer Purchase of Accuray TomoTherapy(R) System
Thu, 19 Oct 2017 13:02:17 GMT

SUNNYVALE, Calif., Oct. 19, 2017 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Court of Appeal of Nantes has rejected the appeal filed by Varian Medical Systems opposing the purchase of the Accur...
Devices, Oncology, Litigation
Accuray, Varian Medical Systems, TomoTherapy, radiotherapy, IMRT

Johnson and Johnson Medical GmbH to Acquire Surgical Process Institute
Thu, 19 Oct 2017 12:52:09 GMT

Acquisition strengthens surgical solutions portfolio with innovative tools designed to minimize variability in care NORDERSTEDT, Germany, Oct. 19, 2017 -- (Healthcare Sales & Marketing Network) -- Johnson & Johnson Medical GmbH today announced a defini...
Devices, Surgery, Mergers & Acquisitions
Johnson & Johnson, Surgical Process Institute

OncoSec Presents Positive Phase 2 Data for ImmunoPulse(R) IL-12 in Combination with Pembrolizumab Demonstrating a Best Overall Response Rate (BORR) of 50% in Predicted Anti-PD-1 Non-Responder Melanoma Patients
Thu, 19 Oct 2017 12:45:10 GMT

Data from Recently Completed Phase 2 Monotherapy and Combination Therapy Studies Presented at the 2017 9th World Congress of Melanoma - A Joint Meeting with the Society for Melanoma Research 8 of 21 (38.1%) Achieved RECIST v1.1 Durable Complete Response...
Biopharmaceuticals, Oncology
OncoSec Medical, ImmunoPulse IL-12, melanoma, immunotherapy

DarioHealth Gains CE Mark for iPhone 7 and iPhone 8 Smart Glucose Meter
Wed, 18 Oct 2017 15:47:01 GMT

DarioHealth Bringing its Lightning®-enabled Version to the UK Market CAESAREA, Israel, Oct. 18, 2017 -- (Healthcare Sales & Marketing Network) -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big ...
Devices, Monitoring, Endocrinology, Regulatory
DarioHealth, Blood Glucose Monitor, Blood Glucose

Source: HSMN NewsFeed